Donations Made and Received: A Study of Disclosure Practices of Pharmaceutical Companies and Patient Groups in Canada
Given the increasing role of patient groups in pharmaceutical policy-making in Canada, this observational study was undertaken to determine whether companies that are members of Innovative Medicines Canada (IMC) list, on their publicly available websites, the names of patient groups that they make d...
Saved in:
Main Author: | Joel Lexchin (Author) |
---|---|
Format: | Book |
Published: |
Kerman University of Medical Sciences,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmaceutical company spending on research and development and promotion in Canada, 2013-2016: a cohort analysis
by: Joel Lexchin
Published: (2018) -
Medicine donations: a review of policies and practices
by: Hannah Permaul Flores, et al.
Published: (2023) -
Development Time and Patent Extension for Prescription Drugs in Canada: A Cohort Study
by: Joel Lexchin
Published: (2021) -
Models for financing the regulation of pharmaceutical promotion
by: Lexchin Joel
Published: (2012) -
It's Time to Finally Kill the Zombies; Comment on "Universal Pharmacare in Canada"
by: Joel Lexchin
Published: (2020)